Subsidy programme for fertility preservation in men undergoing oncological treatment
"Health policy programme on fertility preservation in patients treated with oncology in the Lower Silesian Voivodship" for 2024-2025."
The organiser is the Marshal's Office of the Lower Silesian Voivodship.
It is important that a patient who hears a cancer diagnosis knows that cancer treatment can affect fertility loss. But also that she can safeguard her fertility before starting treatment.
Thanks to the "Health policy programme on fertility preservation in patients treated with oncology in the Lower Silesian Voivodeship" for 2024-2025." Patients can benefit and safeguard their fertility with funding from the Office of the Marshal of the Lower Silesian Voivodship.
At the clinic Invimed in Wroclaw we have been helping patients affected by cancer for years preserve fertility thinking about their future and how we can help them if they want to try to have offspring after treatment.
Programme details
The procedure only applies to fertility preservation in men who have a known oncological or haematological disease.
Medical requirements:
- a certificate from an oncologist or haematologist
- medical documentation substantiating the oncological or haematological disease
Administrative requirements:
- the age of the Scheme Participant is between 18 and 40 by birth year
- The participant resides in the Lower Silesian Voivodship
- Participant takes part for the first time in a grant
For Patients:
- qualifying visit
- medical appointment,
- carrying out the tests required by the Act
- semen vitrification,
- storage of material for 24 months (for qualified Programme participants).
Effect of radiotherapy on male fertility
In a man who has been diagnosed with cancer (e.g. colorectal cancer, prostate cancer, liver cancer, testicular cancer or any other type of cancer), undergoing radiotherapy in the testicular and pelvic region, the process of sperm formation and maturation can be disrupted by even small doses of radiation. Large - can lead to permanent loss of fertility.
The patient's reproductive function can also be threatened by irradiation of the abdomen and head (especially the pituitary and hypothalamus, responsible for the production of the hormones LH and FSH, which stimulate the testes to synthesise testosterone, and the growth and maturation of sperm.
In clinical practice, almost all oncology patients experience temporary or permanent azoospermia (i.e. no sperm in the semen).
Chemotherapy and fertility. Radiotherapy and fertility.
You can safeguard your fertility, by submitting suitably treated semen for freezing, before starting cancer therapy, if you have been diagnosed with one of the following diseases:
- colorectal cancer
- prostate cancer
- testicular cancer
- gastric cancer
- liver cancer
- bladder cancer
- prostate cancer
- prostate cancer
IMPORTANT
During radiotherapy, a man may be fertile, but this is not a good time to conceive a child as his sperm may be damaged. It is usually recommended that patients start trying for a child no sooner than 6-24 months after the end of cancer treatment. It takes at least two years to restore the spermatogenesis process after chemotherapy and only after this time should efforts be made to have a child.
This is why fertility preservation - sperm preservation - before starting oncotherapy, is so important.
More on securing fertility before starting cancer treatment
How to apply for the Programme?
To apply for the Programme and obtain the necessary information, all you need to do is:
- Call the Medical Care Coordinator of the clinic Invimed Wrocław: 511 856 819,
- write to: dofinansowanie.wroclaw@invimed.pl,
- sign up at the reception of the Invimed clinic in Wrocław,
- call the clinic's helpline: 500 900 888.
